Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Pharma’s Path to Adopting AI and Other Emerging Technologies

Posted on February 7th, 2018 by in Pharma R&D

Right now in the pharmaceutical space, emerging technologies are dominating the conversation. As the cost of drug development soars, and the potential for success seems more and more elusive, the industry is pinning its hopes on promising technological breakthroughs. Continue reading “Pharma’s Path to Adopting AI and Other Emerging Technologies” »

Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference

Posted on January 19th, 2018 by in Pharma R&D

The 2018 J.P. Morgan Healthcare Conference, held in San Francisco from January 8-11, came and went in a whirlwind. Continue reading “Drug Development Insights from the 36th Annual J.P. Morgan Healthcare Conference” »

Translational Medicine, Data Access and Pharmaceutical Innovation

Posted on January 17th, 2018 by in Pharma R&D

Some of the early seeds of translational medicine were planted in 1992 when the U.S. National Cancer Institute introduced a program designed to improve and accelerate the knowledge exchange between basic and clinical science. Continue reading “Translational Medicine, Data Access and Pharmaceutical Innovation” »

Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle

Posted on December 22nd, 2017 by in Pharma R&D

Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. Continue reading “Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle” »

  1. 1
  2. 2
  3. 3
  4. 11